March 12, 2025
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global health technology leader, has been named the top-ranked medical technology company in Clarivate’s Top 100 Global Innovators 2025. This continues Philips’ established reputation for innovation within the healthcare sector. The company has consistently appeared in this prestigious ranking of global innovators for twelve years running.
“At Philips, we’ve been innovating for over 130 years to improve people’s lives,” said Roy Jakobs, CEO of Royal Philips. “Innovation is our fundamental strength. It’s the reason our customers choose us as strategic partners and a key value driver for our company. Our portfolio of patient- and people-centric innovations in hardware, software, AI, and services drives healthcare productivity, empowering individuals to manage their health and well-being, and delivering better care for more people.”
In 2024, Philips invested approximately EUR 1.7 billion – representing over 9% of sales – in research and development. Philips emphasizes data and AI in its innovation efforts for both hospitals and home settings. The company is a leader in AI-related healthcare patent applications, dedicating roughly half of its R&D staff to these areas.
Examples of Philips’ AI-driven innovations include:
- The Philips CT 5300, which uses integrated hardware, software, and AI to offer excellent screening, diagnostics, and interventional imaging to more patients.
- The latest SmartSpeed Precise MRI technology, allowing scans to be completed up to three times faster with maintained image quality.
- The AI-enabled cardiovascular ultrasound platform, equipped with advanced AI tools for improved imaging, automation and productivity.
- The Azurion image-guided therapy system and advanced informatics, designed to improve minimally invasive diagnosis and treatment of stroke and other neurovascular conditions.
The Top 100 Global Innovators analysis examines international invention data to assess the strength of patented ideas, using measures linked to their innovative power. The complete report can be viewed online. For further information, please contact:
Ben Zwirs Philips Global External Relations Tel.: +31 61521 3446 E-mail: media@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient-and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.
Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,800 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
